Yuya Hayashi
Kumamoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Hepatocyte-Targeted Delivery of siRNA Polyplex with PEG-Modified Lactosylated Dendrimer/Cyclodextrin Conjugates for Transthyretin-Related Amyloidosis Therapy.
Journal: Biological & pharmaceutical bulletin
Published: October 05, 2019
Recent Advances in Oligonucleotide-Based Therapy for Transthyretin Amyloidosis: Clinical Impact and Future Prospects.
Journal: Biological & pharmaceutical bulletin
Published: December 04, 2018
In vitro and in vivo siRNA delivery to hepatocyte utilizing ternary complexation of lactosylated dendrimer/cyclodextrin conjugates, siRNA and low-molecular-weight sacran.
Journal: International journal of biological macromolecules
Published: July 21, 2017
A clue to unprecedented strategy to HIV eradication: "Lock-in and apoptosis".
Journal: Scientific reports
Published: January 10, 2017
Inhibition of insulin amyloid fibril formation by cyclodextrins.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: July 24, 2015
Recent advances in cyclodextrin delivery techniques.
Journal: Expert opinion on drug delivery
Published: June 23, 2015
Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a siRNA carrier for the treatment of familial amyloidotic polyneuropathy.
Journal: Journal of drug targeting
Published: July 23, 2014
Effect of brazilian propolis on exacerbation of respiratory syncytial virus infection in mice exposed to tetrabromobisphenol a, a brominated flame retardant.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: June 03, 2013
Design and evaluation of polyamidoamine dendrimer conjugate with PEG, α-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo.
Journal: Journal of drug targeting
Published: April 11, 2013
Systemic delivery of transthyretin siRNA mediated by lactosylated dendrimer/α-cyclodextrin conjugates into hepatocyte for familial amyloidotic polyneuropathy therapy.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: April 24, 2012
Potential use of lactosylated dendrimer (G3)/α-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy.
Journal: Molecular pharmaceutics
Published: April 19, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026